Ethylene

Ethylene

SCHEMBL2277946

C=C.CCCCCCCCc1ccccc1O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.59
BID P55957 3/20 0.58
MCL1 Q07820 3/20 0.58
BCL2L1 Q07817 2/20 0.58
BAK1 Q16611 2/20 0.58
KAT8 Q9H7Z6 2/20 0.58
SAE1 Q9UBE0 2/20 0.58
PPARG P37231 1/20 0.58
PPARA Q07869 1/20 0.58
EP300 Q09472 1/20 0.58
KAT2A Q92830 1/20 0.58
KAT2B Q92831 1/20 0.58
KAT5 Q92993 1/20 0.58
TYR P14679 2/20 0.58
MAPT P10636 2/20 0.58
ALOX15 P16050 2/20 0.58
MEN1 O00255 1/20 0.58
TP53 P04637 1/20 0.58
CYP3A4 P08684 1/20 0.58
ALOX5 P09917 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL8990626 1.00 LIPG (0.59) LIPGBIDMCL1BCL2L1BAK1
Ethylene SCHEMBL11700642 1.00 LIPG (0.59) LIPGBIDMCL1BCL2L1BAK1
Ethylene SCHEMBL182993 1.00 LIPG (0.59) LIPGBIDMCL1BCL2L1BAK1
Ethylene SCHEMBL481579 1.00 LIPG (0.59) LIPGBIDMCL1BCL2L1BAK1
Ethylene SCHEMBL10948549 1.00 LIPG (0.59) LIPGBIDMCL1BCL2L1BAK1
Ethylene SCHEMBL27297446 0.98 LIPG (0.58) LIPGBIDMCL1BCL2L1BAK1
Ethylene SCHEMBL28151297 0.98 LIPG (0.58) LIPGBIDMCL1BCL2L1BAK1
SCHEMBL11205038 0.96 LIPG (0.63) LIPGBIDMCL1BCL2L1BAK1
SCHEMBL273583 0.96 LIPG (0.63) LIPGBIDMCL1BCL2L1BAK1
SCHEMBL2922317 0.96 LIPG (0.63) LIPGBIDMCL1BCL2L1BAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109457264-A A kind of modified graphene oxide degreaser and its preparation method and application 广东坚美铝型材厂(集团)有限公司 2019-03-12 CN claimed
CN-109208013-A A kind of modified graphene oxide degreaser and its preparation method and application 广东坚美铝型材厂(集团)有限公司 2019-01-15 CN claimed
CN-109208014-A A kind of modified graphene oxide degreaser and its preparation method and application 广东坚美铝型材厂(集团)有限公司 2019-01-15 CN claimed
EP-2834355-A1 POLYSILICATE-POLYSILICONE ENZYME IMMOBILIZATION MATERIALS Akermin, Inc. (US) 2015-02-11 EP claimed
WO-2013151757-A1 POLYSILICATE-POLYSILICONE ENZYME IMMOBILIZATION MATERIALS AKERMIN, INC. (US) 2013-10-10 WO claimed
EP-2362809-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE Akermin, Inc. (US) 2011-09-07 EP claimed
WO-2010037109-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE AKERMIN, INC. (US) 2010-04-01 WO claimed
CN-109457264-A A kind of modified graphene oxide degreaser and its preparation method and application 广东坚美铝型材厂(集团)有限公司 2019-03-12 CN disclosed
CN-109208014-A A kind of modified graphene oxide degreaser and its preparation method and application 广东坚美铝型材厂(集团)有限公司 2019-01-15 CN disclosed
CN-109208013-A A kind of modified graphene oxide degreaser and its preparation method and application 广东坚美铝型材厂(集团)有限公司 2019-01-15 CN disclosed
EP-3386593-A1 IMMUNOMODULATING COMPOSITION FOR TREATMENT Admedus Vaccines Pty Ltd (AU) 2018-10-17 EP disclosed
CN-105745318-B For collecting the devices, systems, and methods of target substance 瑞尔赛特股份有限公司 2018-06-12 CN disclosed
US-9890374-B2 Thermostable carbonic anhydrases and methods of use thereof DANISCO US INC (US) 2018-02-13 US disclosed
US-20100086983-A1 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE AKERMIN, INC. (US) 2010-04-08 US disclosed
WO-2010037109-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE AKERMIN, INC. (US) 2010-04-01 WO disclosed
US-7186686-B2 Containing mixtures of oppositely-charged polypeptides such as insulin-like growth factor and insulin; treatment of type II diabetes GENENTECH, INC. (US) 2007-03-06 US disclosed
EP-0745139-B1 PROCESS FOR PREPARING AND HYBRIDIZING SPECIFIC PROBES CREMER CRISTOPH (DE) 2002-04-24 EP disclosed
WO-1993000357-A1 THERAPEUTIC POLYPEPTIDES BASED ON VON WILLEBRAND FACTOR RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1993-01-07 WO disclosed
US-4707439-A Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1987-11-17 US disclosed
US-3951885-A Method of making magnesium oxychloride cement cofoamed with synthetic resin THOMPSON CHEMICALS, INC. (US) 1976-04-20 US disclosed